SEC Form D · Amendment · filed December 20, 2017
Jecure Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Ariel Feldstein, M.D · San Diego, CADirectorThomas Woiwode, Ph.D · San Francisco, CADirectorJames Veal, Ph.D · San Diego, CAExecBradley Bolzon, Ph.D · San Diego, CADirectorJeffrey Stafford, Ph.D · San Diego, CAExec · DirectorPeter Kambolin · New York, NYExec · DirectorMatthew C. Mcclelland · Trenton, MIDirectorSame Systematic Alpha Cryptocurrency GP, LLC · New York, NYDirectorJay Luo Jiabin · Singapore, U0ExecJeffrey Zielinski · Singapore, U0DirectorDaniel J. Goldstein · Rochester, NYExecE. P. Saunders · Rochester, NYDirectorCharles R. Knittle · Rochester, NYExec · DirectorBruce E. Bender · Rochester, NYDirectorAleksandrs Zavoronkovs · London, United KingdomDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗